Thelansis

  Sezary syndrome (SS) is an aggressive form of cutaneous T-cell lymphoma which is a group of disorders that occur when T-cells (a type of white blood cell) become cancerous and affect the skin.  It is characterized by a widespread red rash that may cover most of the body, the presence of cancerous T cells (called Sezary cells) in the blood, and abnormally enlarged lymph nodes.   Etiology- Sezary syndrome are associated with human T-lymphotropic viruses type 1 and type 2, the underlying cause of most cases is currently unknown.   Epidemiology- SS has an annual incidence rate of 1/10,000,000 and represents 3% of all cutaneous lymphomas.     The competitive landscape of Cutaneous T-cell lymphoma (Sezary Syndrome) includes country-specific approved as well as pipeline therapies. Any asset/product-specific designation or review and Accelerated Approval are being tracked and supplemented with analyst commentary. KOLs insights of Cutaneous ...